Ann Arbor, MI — There is a growing demand from medical research institutions for high resolution, compact imaging tools to better study disease progression in areas such as cancer, cardiovascular and neurodegenerative diseases and to develop novel treatments including radiotherapies. The first systems from MH3D, US-based innovator in compact pre-clinical single photon emission computed tomography […]

LINCOLN, NE and Heidelberg, Germany – LICORbio, a leading innovator in life science imaging and analytical solutions, today announced the acquisition of SERVA Electrophoresis, a privately held company known for its high-quality electrophoresis reagents, consumables, and workflow instrumentation. The transaction strengthens LICORbio’s position as a comprehensive solutions provider in protein analysis and enhances its commitment to […]

WESTMINSTER, CA / BioLargo, Inc. (OTCQX:BLGO), a company that creates and commercializes sustainable technologies to solve tough environmental and cleantech challenges, has commenced “alpha testing” of a PFAS-detecting portable water test kit developed by Verralize, Inc., an innovator of next-generation water testing technologies. Verralize’s “lab-on-a-sensor” test kit enables rapid, on-site detection of per- and polyfluoroalkyl […]

ICO has as of today completed the divestment of MatTek and Visikol to Sartorius, for USD 80m on a cash and debt-free basis, after customary regulatory approval has been obtained. Following transaction costs, net debt and working capital adjustments net proceeds are estimated to amount to USD 77.2m. The divestment follows the Group’s updated strategy […]

Expanding capabilities in delivering scalable, high-quality synthetic DNA solutions to the global market Cambridge, UK – 4basebio PLC (AIM: 4BB) (“4basebio”), a specialist in synthetic DNA manufacturing and nucleic acids for next-generation therapeutics, today announced refreshed branding and the launch of its new website, reflecting the company’s continued growth and success in this rapidly advancing field. […]

Saint-Germain-en-Laye, France – Takara Bio Europe is pleased to announce it has entered into a distribution agreement with MACHEREY-NAGEL (MN), a leading global provider of analytical and bioanalytical products. Under this agreement, Takara Bio Europe will distribute MN’s Bioanalysis portfolio in Austria, Belgium, Denmark, France, Germany, Ireland, Luxemburg, Sweden, Switzerland and the United Kingdom. MN’s Bioanalysis […]

Genovis AB (publ) (“Genovis”) today announces that it has exercised its call option to acquire the remaining 75% of SEQURNA AB (“SEQURNA” or “Company”), a strategic move that accelerates Genovis’ expansion into the fast-growing genomics sector. This acquisition unlocks new product offerings for Genovis to both existing and new customers and further paves the way […]

 Enabling Scalable, Non-Viral Cell Engineering for Research, Biomanufacturing, and Therapeutic Development — TOKYO — The Biomedical Division of PHC Corporation (Headquarters: Chiyoda-ku, Tokyo; President: Nobuaki Nakamura; hereafter referred to as “PHCbi”), a subsidiary of PHC Holdings Corporation (Headquarters: Chiyoda-ku, Tokyo, hereafter referred to as “PHCHD”) announces it has signed an exclusive agreement with MaxCyte, Inc. […]

Breakthrough proteomics platform technology unlocks full-length protein sequencing and characterisation, accelerating drug development and diagnostics The NATO Innovation Fund and Earlybird led a $35 million Series A round in Portal Biotech, a pioneering biotechnology company headquartered in London. This represents one of Europe’s largest investments into a life sciences tools company and positions Portal Biotech […]

Financing to accelerate commercialization of flagship products, service business, and entrance into U.S. market STOCKHOLM — Epigenica AB, a pioneer in high-throughput epigenetic screening tools and solutions, announced today that it has closed a $2.2 million round (SEK 21.5M) to fuel its growth and commercial expansion across key markets. This round was led by Voima Ventures, a Nordic early-stage […]